179 related articles for article (PubMed ID: 35277915)
1. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer.
Xia N; Yang N; Shan Q; Wang Z; Liu X; Chen Y; Lu J; Huang W; Wang Z
J Cell Mol Med; 2022 Apr; 26(8):2322-2336. PubMed ID: 35277915
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.
Park YM; Hwang SJ; Masuda K; Choi KM; Jeong MR; Nam DH; Gorospe M; Kim HH
Mol Cell Biol; 2012 Oct; 32(20):4237-44. PubMed ID: 22907752
[TBL] [Abstract][Full Text] [Related]
3. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3.
Yang N; Liu L; Liu X; Chen Y; Lu J; Wang Z
Biomed Res Int; 2022; 2022():6319685. PubMed ID: 35355828
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
[TBL] [Abstract][Full Text] [Related]
5. HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression.
Liu D; Luo X; Xie M; Zhang T; Chen X; Zhang B; Sun M; Wang Y; Feng Y; Ji X; Li Y; Liu B; Huang W; Xia L
Cancer Sci; 2022 Oct; 113(10):3347-3361. PubMed ID: 35848884
[TBL] [Abstract][Full Text] [Related]
6. HNRNPC impedes m
Huang XT; Li JH; Zhu XX; Huang CS; Gao ZX; Xu QC; Zhao W; Yin XY
Cancer Lett; 2021 Oct; 518():196-206. PubMed ID: 34271104
[TBL] [Abstract][Full Text] [Related]
7. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.
Xu J; Zhu W; Xu W; Cui X; Chen L; Ji S; Qin Y; Yao W; Liu L; Liu C; Long J; Li M; Yu X
Int J Oncol; 2013 Jun; 42(6):2046-52. PubMed ID: 23588667
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Role of Heterogeneous Nuclear Ribonucleoprotein C in Multiple Cancer Types, with a Particular Focus on Lung Adenocarcinoma, Using a Pan-Cancer Analysis and Cell Line Experiments.
Zhang L; Peng H; Jiang L
J Environ Pathol Toxicol Oncol; 2022; 41(3):77-93. PubMed ID: 35993957
[TBL] [Abstract][Full Text] [Related]
9. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.
Souchek JJ; Baine MJ; Lin C; Rachagani S; Gupta S; Kaur S; Lester K; Zheng D; Chen S; Smith L; Lazenby A; Johansson SL; Jain M; Batra SK
Br J Cancer; 2014 Sep; 111(6):1139-49. PubMed ID: 25025965
[TBL] [Abstract][Full Text] [Related]
10. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
[TBL] [Abstract][Full Text] [Related]
11. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer.
Yu YM; Hu Y
Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903
[TBL] [Abstract][Full Text] [Related]
12. HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.
Huang H; Han Y; Zhang C; Wu J; Feng J; Qu L; Shou C
Tumour Biol; 2016 Mar; 37(3):3527-34. PubMed ID: 26453116
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
[TBL] [Abstract][Full Text] [Related]
14. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
[TBL] [Abstract][Full Text] [Related]
15. A systematic pan-cancer study demonstrates the oncogenic function of heterogeneous nuclear ribonucleoprotein C.
Pan C; Wu Q; Feng N
Aging (Albany NY); 2022 Mar; 14(6):2880-2901. PubMed ID: 35344508
[TBL] [Abstract][Full Text] [Related]
16. Identification of genetic variants in m
Ying P; Li Y; Yang N; Wang X; Wang H; He H; Li B; Peng X; Zou D; Zhu Y; Zhong R; Miao X; Tian J; Chang J
Arch Toxicol; 2021 Mar; 95(3):1117-1128. PubMed ID: 33474615
[TBL] [Abstract][Full Text] [Related]
17. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
[TBL] [Abstract][Full Text] [Related]
18. Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.
Chen XY; Wang Z; Li B; Zhang YJ; Li YY
Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481
[TBL] [Abstract][Full Text] [Related]
19. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder.
Niggl E; Bouman A; Briere LC; Hoogenboezem RM; Wallaard I; Park J; Admard J; Wilke M; Harris-Mostert EDRO; Elgersma M; Bain J; Balasubramanian M; Banka S; Benke PJ; Bertrand M; Blesson AE; Clayton-Smith J; Ellingford JM; Gillentine MA; Goodloe DH; Haack TB; Jain M; Krantz I; Luu SM; McPheron M; Muss CL; Raible SE; Robin NH; Spiller M; Starling S; Sweetser DA; Thiffault I; Vetrini F; Witt D; Woods E; Zhou D; ; ; Elgersma Y; van Esbroeck ACM
Am J Hum Genet; 2023 Aug; 110(8):1414-1435. PubMed ID: 37541189
[TBL] [Abstract][Full Text] [Related]
20.
Wang F; Xia X; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ; Mitra S; Ferrari M; Shen H
Clin Cancer Res; 2018 Jul; 24(13):3176-3185. PubMed ID: 29602802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
